Literature DB >> 9741327

Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone.

T Yoneda1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741327     DOI: 10.1016/s0959-8049(97)10132-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  20 in total

1.  Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.

Authors:  Zhong Dong; R Daniel Bonfil; Sreenivasa Chinni; Xiyun Deng; J Carlos Trindade Filho; Margarida Bernardo; Ulka Vaishampayan; Mingxin Che; Bonnie F Sloane; Shijie Sheng; Rafael Fridman; Michael L Cher
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

2.  Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.

Authors:  I Leav; K M Lau; J Y Adams; J E McNeal; M E Taplin; J Wang; H Singh; S M Ho
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Association of the metastatic phenotype with CCN family members among breast and oral cancer cells.

Authors:  Toshihiro Ohgawara; Satoshi Kubota; Harumi Kawaki; Naito Kurio; Tarek Abd El Kader; Mitsuhiro Hoshijima; Danilo Janune; Tsuyoshi Shimo; Bernard Perbal; Akira Sasaki; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2011-04-18       Impact factor: 5.782

4.  Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment.

Authors:  Taichi Kimura; Takeshi Kuwata; Satoshi Ashimine; Manabu Yamazaki; Chisako Yamauchi; Kanji Nagai; Akashi Ikehara; Yang Feng; Dimiter S Dimitrov; Seiichi Saito; Atsushi Ochiai
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

5.  Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.

Authors:  Izabela Podgorski; Bruce E Linebaugh; Mansoureh Sameni; Christopher Jedeszko; Sunita Bhagat; Michael L Cher; Bonnie F Sloane
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

6.  HER-2/neu genotype of breast cancer may change in bone metastasis.

Authors:  Tamás Lôrincz; József Tóth; Gayane Badalian; József Tímár; Miklós Szendrôi
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

7.  Alterations of microvascular density in bone metastases of adenocarcinomas.

Authors:  Tamás Lôrincz; József Tímár; Miklós Szendrôi
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

8.  Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.

Authors:  Zhong Dong; Allen D Saliganan; Hong Meng; Sanaa M Nabha; Aaron L Sabbota; Shijie Sheng; R Daniel Bonfil; Michael L Cher
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

Review 9.  Applications of transgenics in studies of bone sialoprotein.

Authors:  Jin Zhang; Qisheng Tu; Jake Chen
Journal:  J Cell Physiol       Date:  2009-07       Impact factor: 6.384

10.  Cancer metastasis networks and the prediction of progression patterns.

Authors:  L L Chen; N Blumm; N A Christakis; A-L Barabási; T S Deisboeck
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.